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Abstract
The waste of commonly used medicines is known to contaminate freshwater ecosystems.
Pharmaceuticals can be toxic, mutagenic, or modifying to freshwater organisms even at low
concentrations if consider their permanent presence in the environment. Chemotherapeu-
tics used to treat cancer, and in particular alkylating agents, contribute significantly to this
form of pollution, the latter introducing cytotoxic and/or mutagenic lesions to the DNA and
RNA of organisms which can be disruptive to their cells. The aim of the present study was to
investigate the influence of the alkylating anticancer agent cyclophosphamide (CP) on
Daphnia magna clones. We evaluated the life history parameters and protein profiles of this
crustacean following exposure to environmentally relevant CP concentration of 10 ng L-1.
Even at this low concentration, the alkylating agent caused modification of the life history
parameters and proteome profile of the Daphnia. These changes were clone-specific and
involved growth rate, age at first reproduction, neonate number, and proteins related to cell
cycle and redox state regulation. The disturbance caused by pharmaceuticals contaminat-
ing freshwater ecosystem is probably weaker and unlikely to be cytotoxic in character due to
the high dilution of these substances in the water. However, our results indicate that pro-
longed exposure of organisms to these toxins may lead to modifications on the organismal
and molecular levels with unpredictable significance for the entire ecosystem.
Introduction
Commonly used pharmaceuticals have been found to be significant pollutants of aquatic eco-
systems [1–3]. These substances, including anti-cancer agents, have been detected in the sur-
face waters of many countries due to an increase in the consumption of medicines over the
past decade [4–6]. In 2011, the UK Office of National Statistics predicted that the use of phar-
maceuticals in Great Britain would at least double by 2050 (UK Office of National Statistics
2011 https://www.ons.gov.uk). This phenomenon is occurring primarily due to the aging of
society as well as the increase in frequency of so-called diseases of affluence, such as type 2
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diabetes, heart disease, metabolic syndrome, depression, obesity and cancer. Pharmaceuticals
enter sewage treatment plants mainly following their consumption and subsequent excretion
by people, or directly by flushing the overdue medicines themselves down toilets [7–9].
Alkylating agents, including those used as chemotherapeutics, contribute significantly to the
contamination of freshwater ecosystems [10]. This group of chemicals represents the oldest
class of anticancer agents to have been developed and is still used despite the introduction of tar-
geted therapies. Alkylating agents modifying DNA, RNA and proteins by alkylation, create
byproducts which, if not removed, can be toxic or mutagenic to the cell. At high concentrations
they can lead to cell death or, in higher organisms, various kinds of cancer. Cyclophosphamide
(CP) is an oxazaphosphorine-type chemical with its main effect on cells caused by its metabo-
lite, phosphoramide mustard formed only in cells with high levels of aldehyde dehydrogenase.
Phosphoramide mustard creates DNA crosslinks both between and within DNA strands at gua-
nine N-7 positions, known as interstrand and intrastrand crosslinkers, respectively. This dam-
age is irreversible and leads to cell apoptosis [11]. CP can be used in chemotherapy to treat
blood cancer, solid tumours, and sarcoma by targeting the affected cells.
The impact of pharmaceuticals on organisms is often tested in laboratories at higher con-
centrations (i.e. miligrams per litre) than are found in the environment (i.e. nanograms per
litre) [12, 13]. Studies monitoring the concentrations of pharmaceuticals in surface waters
have shown them to be low (ng L-1); these substances are, however, being released into the
water on a constant basis [14]. The scarcity of research into the effects of the low- concen-
trations of pharmaceuticals found in the environment on so-called non-target organisms,
which was highlighted by Fent et al.2006 [15], remained a problem for about a decade.
Recently concentrations of pharmaceuticals as present in freshwater ecosystems have come
into focus. Medicine have been shown to significantly affect the functioning of aquatic bio-
films [16]. Environmental concentrations of pharmaceuticals can also significantly affect
primary producers (algae) crossing two trophic planktonic levels, affecting Daphnia [17].
D. magna, a keystone species inhabiting lakes and ponds in Europe, is a model organism
which has been frequently used for research on the molecular mechanisms of phenotypic plas-
ticity, adaptation, and microevolution [18, 19]. Its ecology and response to stressors are well-
understood by researchers [15–20]. Aim of present study was to examine if the exposure of D.
magna to low concentrations of CP results in modification of its life history parameters and
changes in its proteome profiles.
Materials and methods
Pharmaceutical materials
Cyclophosphamide monohydrate (CP) was provided by SIGMA (C7397-1G). We used a stock
solution containing 1 mg mL-1 of CP in de-ionized water. Daphnia were exposed to the CP at
the concentration normally detected in freshwater ecosystems [4], namely 10 ng L-1.
Daphnia magna clones
We used three D. magna clones in the experiment, referred to as D, N and S, taken from three
separate reservoirs in the same region in order to obtain different genotypes while keeping
environmental conditions relatively constant. The clones came from three ponds in the sub-
urbs of Ceske Budejovice, Czech Republic in May 2016: D was obtained from Domin (49.00N,
14.43E), N was from Novy Vrebensky Rybnik (49.00N, 14.44E) and S was from Stary Vre-
bensky Rybnik (49.01N, 14.43E). There was no need for permission for the collection of ani-
mals from specified lakes. To avoid any maternal effect, the clones were cultured for at least 3
generations in the laboratory prior to the experiment. Thus, neonates from the second clutch
Daphnia magna response to low doses of cyclophosphamide
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were used for further breeding and in experiment. The Daphnia clones were cultured under
controlled, constant conditions: each individual was kept in 100 mL of lake water at a tempera-
ture of 20˚C, with dim light-imitating lighting in epilimnion. The lake water, which originated
from Szczęśliwice (Warsaw, Poland), was aerated for at least 4 weeks and filtered through a
0.2 μm capsule filter prior to use. The Daphnia were fed daily with green algae, Acutodesmus
obliquus, at the non-limiting growth concentration of 1 mg Corg L-1 [11]. During the experi-
ment, Daphnia clones were either cultured without or in the presence of CP (10 ng L-1) (con-
trol vs experimental conditions). To avoid the problem of CP decay, the experimental medium
was changed every second day with a fresh dose of CP. Individuals were cultured for up to 11
days until first reproduction. All clones were tested at the same time.
Daphnia magna life history parameters
The experimental design is depicted in Fig 1.
Juvenile somatic growth rates were obtained from 5-day old Daphnia without eggs. At the
beginning of the experiment, five aluminium weighing bottles, each containing three
<24-hour old individuals from each clone were dried (24 h; 60˚C) and weighed after 24 h. In
addition, 10 5 day-old animals from each clone were weighed after 24 h of drying (one individ-
ual per weighing bottle). The Daphnia were weighed using an Orion Cohn C-35 Microbalance
Thermo Scientific (exact to within 0.1 μg). Juvenile somatic growth rates (g) were measured
via the increase in dry mass of the Daphnia between the beginning of the experiment (Wt0)
and day 5 (Wt1), using the equation [20]:
g ¼
lnWt1   lnWt0
t1   t0
Age at first reproduction was noted and number of offspring was counted every 24 h.
When they reached the age of first reproduction, the Daphnia were photographed and mea-
sured using the NIS Nikon System.
Fig 1. The experimental design (description in the text).
https://doi.org/10.1371/journal.pone.0195366.g001
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Mass spectrometry analyses of protein profiles
Analyses were performed on juvenile (5-day old) animals without eggs from all three of the
D. magna clones. First, in order to clean their guts, both experimental groups, control and
CP-treated, were placed in a medium without food. Each sample was then prepared in qua-
druplet (except for the treated D clone, which was prepared in triplicate due to a shortage of
individuals), each containing 5 Daphnia.
The Daphnia were then dried on a filter, homogenized and resuspended in a RIPA buffer
in the presence of a protease inhibitor cocktail. Cellular debris was spun at 30,130 x g and
the resulting supernatant was analyzed for protein content using the Bradford assay [21].
Samples were diluted with SDS-PAGE loading buffer to achieve a final protein concentra-
tion of 2 μg μL-1, and 10 μL was loaded on the Mini-PROTEAN TGX 4–15% gradient gel
(Bio-Rad). Protein bands were cut out of the gel and used for mass spectrometry analysis.
Venn diagrams were generated using webtool (http://bioinformatics.psb.ugent.be/webtools/
Venn) and prepared with Gimp 2.8.14 software.
The functions of the proteins were retrieved from the UniProt database [22].
Statistical analysis
Data were analysed using an ANOVA model. All analyses were carried out using the software
programs Statistica 8 and Origin.
Results
Growth rate
Compared to the untreated controls, the growth rate of the D. magna individuals exposed to
CP was lower in all three clones, by approx. 5% (clone D), 2.5% (clone N) and 5% (clone S)
(Fig 2), although none of these differences were statistically significant (One way ANOVA
clone D: F(1, 17) = 1.81, p = 0.196; clone N: F(1, 17) = 0.386, p = 0.542; clone S: F(1, 15) = 0.671,
p = 0.425).
Age at first reproduction
CP had an effect on the age at first reproduction of clone S (Fig 3A), with the individuals
maturing later (10 days old) when cultured with CP compared to those Daphnia which were
not exposed to the pharmaceutical (9.5 days old) (One way ANOVA: F(1, 18) = 5, p = 0.038).
The age at the first reproduction was not affected by the presence of the alkylating agent in the
other two clones (6 vs 6.4 days experimental vs control old for clone D and 6.4 vs 6.3 days old
for clone N).
Size at first reproduction
The addition of the pharmaceutical had no significant effect on size at the first reproduction
on any of the D. magna clones tested (Fig 3B) (Clone D: 2.53 mm vs 2.50 mm control vs exper-
imental; Clone N: 2.79 vs 2.84 mm; Clone S: 2.40 and 2.38 mm).
Number of neonates at first reproduction
D. magna from clones N, D and S, reacted differently to the CP contamination. The number of
first neonates for the N clone was significantly higher (3 more offspring on average, or 38%)
when the animals had been treated with CP (One way ANOVA: F(1, 18) = 9.66, p = 0.006) (Fig
3C). Although D clone animals treated with CP had an average of 1.7 (17%) more neonates
Daphnia magna response to low doses of cyclophosphamide
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than those in the non-treated control, this difference was not statistically significant (One way
ANOVA: F(1, 18) = 2.13, p = 0.162). S clone animals had an average of 7.3 neonates in the first
clutch under both experimental and control conditions (Fig 3C).
Protein differential analysis
In order to identify proteins playing a role in the response of Daphnia to genotoxic pollutants,
we used mass spectrometry. The analysis identified 1192, 1239 and 1230 proteins from the D,
N and S clones, respectively (S1, S2, and S3 Files), of which 10, 12, and 10 proteins were signifi-
cantly changed (q value < 0.1) or appeared only in the untreated organisms of all clone groups
(Fig 4, Tables 1–3). In each clone, only one to three proteins were found to be up- or down-
regulated in the presence of the pharmaceutical. With one exception, there were no proteins
common to the three treatments (Fig 4).
The proteins which appeared or increased significantly in abundance in CP-treated individ-
uals from the D clone were identified as vitellogenin fused with superoxide dismutase and
cytosolic acetyl-CoA acetyltransferase (Fig 4A, Table 1).
The proteins which appeared or increased significantly in abundance in CP-treaded indi-
viduals from the N clone were identified as cyclin-dependent kinase, vesicle-fusing ATPase,
ribosome biogenesis protein WDR12 and V-type proton ATPase catalytic subunit A (Fig 4,
Table 2).
The proteins which appeared or increased significantly in abundance in CP-treated individ-
uals from the S clone were identified as tetratricopeptide repeat protein 39, carboxypeptidase
Fig 2. The influence of cyclophosphamide on the growth of D. magna. (a) Average ± SD growth rate of Daphnia clones D, N
and e S on Day 5, cultured with (grey bars) or without (white bars) cyclophosphamide.
https://doi.org/10.1371/journal.pone.0195366.g002
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B, ADP/ATP translocase, ribosome biogenesis protein WDR12 and mannosyl-oligosaccharide
glucosidase (Fig 4A, Table 3).
In the CP-treated clone D individuals, proteins which were totally inhibited or decreased
significantly in abundance were NADH dehydrogenase [ubiquinone] 1 alpha subcomplex sub-
unit 2, vitellogenin-1 precursor-like protein, glutathione S-transferase theta-1 and ectonucleo-
tide pyrophosphatase/phosphodiesterase (Fig 4B, Table 1).
In the CP-treated clone N individuals, proteins which were totally inhibited or decreased
significantly in abundance were 5-oxoprolinase, trafficking protein particle complex subunit,
cadherin-23, transforming protein RhoA, mannose-6-phosphate isomerase, integrin alpha-
PS4, neutral endopeptidase (neprilysin) and mitochondrial glutamate dehydrogenase (Fig 4B,
Table 2).
In the CP-treated clone S individuals, proteins which were totally inhibited or decreased
significantly in abundance were cytoplasmic FMR1-interacting protein 2 (reelin), importin
subunit alpha-4, oligomeric Golgi complex subunit, vitellogenin-1 precursor-like protein (Fig
4B, Table 3).
Discussion
Cyclophosphamide is an alkylating agent used in anticancer therapy, which has also been
found to be a contaminant of aquatic ecosystems. In this investigation, we studied the influ-
ence of CP on the life history parameters and the proteome of D. magna. Our approach of
using low concentrations of contaminants to match their normal occurrence in the environ-
ment fits in with the latest research [16, 17]. This kind of study go beyond the mere assessment
of the impacts of contaminants on mortality and reproduction and contribute to our under-
standing of the sub-lethal effects of anthropogenic chemicals at the cellular and molecular
levels.
A previous study [23] found that after 21 days of exposure to CP, the Lowest Observed
Effect Concentration (LOEC) in Daphnia was 100 mg L-1 and the No Observed Effect
Fig 3. The influence of cyclophosphamide on the reproduction of D. magna. Average (± SD) (a) age, (b) size at first
reproduction and (c) first neonate number of Daphnia (Clones D, N and S) cultured with (grey bars) or without (white
bars) cyclophosphamide. Stars indicate significant differences between the control and experimental groups.
https://doi.org/10.1371/journal.pone.0195366.g003
Fig 4. Common proteins with changed levels in Daphnia animals treated with cyclophosphamide. A Venn
diagram showing common proteins, either (a) up- or (b) down regulated, in Daphnia, which changed significantly (q
value< 0.1) in the clone D, N and S individuals which had been treated with cyclophosphamide.
https://doi.org/10.1371/journal.pone.0195366.g004
Daphnia magna response to low doses of cyclophosphamide
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Concentration (NOEC) was 56 mg L-1. Warne and van Dam (2008) argued, however, that
NOEC and LOEC data are flawed and should no longer be generated or used [24]. We agree
with this assessment, and thus used CP at met in the environment low concentration of 10 ng
L-1, but prolonged exposition. Pharmaceuticals, highly diluted in freshwater can be expected to
act on organisms rather in modulatory way, with the tendency to strengthen the effect if sup-
plemented over time.
In our study, following 5 days the exposure of D. magna to CP, we found no effect on
growth rate (Fig 2) nor on size at first reproduction. Only one of the tested clones showed reac-
tions to CP regarding age at first reproduction (clone S) and the number of neonates at first
reproduction (clone N) (Fig 3). On the other hand, 5-day old Daphnia treated with CP differed
in their proteome profiles compared to untreated, control animals (Fig 4); thus, an effect of CP
was observed at the molecular level.
All tested clones showed different reactions to exposure to the alkylating agent. Given that
low concentrations of CP as are typically found in the environment are not lethal, we took the
Table 1. Proteins with changed expressions in the D clone individuals which had been treated with CP, compared to control individuals, with q-value< 0.1
(ratio = control (C)/CP treated animals).
no protein qvalue ratio description
1 KZS16579.1 NA only in C Uncharacterized protein APZ42_017126 [Daphnia magna]
2 KZS08626.1 NA only in C NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [Daphnia magna]
3
JAN29398.1
KZS21037.1
NA only in C
Vitellogenin-1 precursor-like protein [Daphnia magna]
Uncharacterized protein APZ42_012128 [Daphnia magna]
4
JAN86019.1
JAN30129.1
KZS21347.1
JAN49269.1
JAN31626.1
JAN31627.1
JAN44428.1
(5 more)
NA only in C hypothetical protein [Daphnia magna]
5
JAN41153.1
KZS11037.1
NA only in C putative Glutathione S-transferase theta-1 [Daphnia magna]
6
JAN56176.1
JAN38323.1
JAN35680.1
JAN35679.1
NA only in C Ectonucleotide pyrophosphatase/phosphodiesterase family member, partial [Daphnia magna]
7
KZS20885.1
JAN57391.1
JAN64473.1
NA only in C
Uncharacterized protein APZ42_012329 [Daphnia magna]
putative Lethal (1) G0193 [Daphnia magna]
Lethal (1) G0193 [Daphnia magna]
8
KZS01522.1
JAN67828.1
JAN44234.1
JAN44235.1
KZS03198.1
KZS00546.1
JAN65939.1
(4 more)
0.02027 0.37
Vitellogenin fused with superoxide dismutase, partial [Daphnia magna]
hypothetical protein [Daphnia magna]
Copper-zinc cu-zn superoxide dismutase-like protein, partial [Daphnia magna]
putative Copper-zinc cu-zn superoxide dismutase, partial [Daphnia magna]
Vitellogenin fused with superoxide dismutase [Daphnia magna]
Vitellogenin fused with superoxide dismutase, partial [Daphnia magna]
hypothetical protein [Daphnia magna]
9
KZS03199.1
KZS00545.1
JAN61085.1
JAN53991.1
JAN44236.1
JAN44237.1
KZS01586.1
(20 more)
0.03012 0.61
Vitellogenin fused with superoxide dismutase [Daphnia magna]
Vitellogenin fused with superoxide dismutase, partial [Daphnia magna]
Copper-zinc cu-zn superoxide dismutase [Daphnia magna]
hypothetical protein, partial [Daphnia magna]
putative Copper-zinc cu-zn superoxide dismutase, partial [Daphnia magna]
putative Copper-zinc cu-zn superoxide dismutase, partial [Daphnia magna]
Vitellogenin fused with superoxide dismutase, partial [Daphnia magna]
10 KZS05119.1 0.03475 0.48 Acetyl-CoA acetyltransferase, cytosolic [Daphnia magna]
https://doi.org/10.1371/journal.pone.0195366.t001
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opportunity to test for various strategies which Daphnia may use to cope with the negative
effects of exposure to CP. Daphnia is well known for its phenotypic plasticity, particularly spec-
tacular in the domain of sex. Males and females from the same clone have the same genotype
and their sexual features are environmentally determined [23]. The different reactions to toxic
substances by different clones can be a result of the species’ micro-evolutionary potential to
develop resistance (in this case to CP). According to Messiaen et al. (2013), the initial tolerance
shown by D. magna to sub-lethal cadmium exposure is the same among several naive
Table 2. Proteins with changed expressions in the N clone individuals which had been treated with CP, compared to control individuals, with q-value< 0.1
(ratio = control/CP treated animals).
no protein qvalue ratio description
1 JAN87821.1 NA only in C 5-oxoprolinase [Daphnia magna]
2
JAN68607.1
JAN75681.1
NA only in C
hypothetical protein [Daphnia magna]
Trafficking protein particle complex subunit [Daphnia magna]
3 KZS17483.1 NA only in C Cadherin-23 [Daphnia magna]
4
JAN85428.1
JAN56086.1
JAN56087.1
JAN58286.1
JAN31693.1
JAN31694.1
NA only in C Transforming protein RhoA [Daphnia magna]
5
JAN88856.1
KZS09065.1
NA only in C Mannose-6-phosphate isomerase [Daphnia magna]
6
JAN66521.1
JAN74852.1
KZS17694.1
NA only in CP
Cyclin-dependent kinase [Daphnia magna]
Eukaryotic translation initiation factor 3 subunit F [Daphnia magna]
Cdk1/cdc2-like protein [Daphnia magna]
7
JAN88015.1
KZS18876.1
NA only in C Integrin alpha-PS4 [Daphnia magna]
8
JAN48978.1
JAN51075.1
JAN36045.1
JAN38730.1
JAN36046.1
JAN45672.1
KZS12965.1
(2 more)
NA only in CP Vesicle-fusing ATPase [Daphnia magna]
9
KZS04920.1
JAN33178.1
JAN67728.1
JAN55609.1
JAN50414.1
JAN86991.1
NA only in CP Ribosome biogenesis protein WDR12 [Daphnia magna]
10
KZS02943.1
JAN56973.1
JAN53933.1
JAN49344.1
JAN47436.1
JAN30488.1
JAN45937.1
(2 more)
0.00240 1.52 Neprilysin (neutral endopeptidase) [Daphnia magna]
11
KZS07135.1
JAN87858.1
0.01443 0.76 V-type proton ATPase catalytic subunit A [Daphnia magna]
12
KZS13935.1
JAN57187.1
JAN51070.1
JAN42923.1
JAN30737.1
JAN70324.1
0.01603 1.38 Glutamate dehydrogenase, mitochondrial [Daphnia magna]
https://doi.org/10.1371/journal.pone.0195366.t002
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populations living in different ponds, but the micro-evolutionary potential of these popula-
tions to develop resistance is very different [25]. It is likely that our clones had already been in
contact with the alkylating agent. Given that they originated from populations which may have
Table 3. Proteins with changed expressions in the S clone individuals which had been treated with CP, compared to control individuals, with q-value< 0.1
(ratio = control/CP treated animals).
no protein qvalue ratio description
1
JAN73747.1
JAN65254.1
JAN62759.1
KZS06757.1
JAN90719.1
NA only in C
60S ribosomal protein L7, partial [Daphnia magna]
60S ribosomal protein L7 [Daphnia magna]
60S ribosomal protein L7, partial [Daphnia magna]
Cytoplasmic FMR1-interacting protein 2 [Daphnia magna]
Reelin [Daphnia magna]
2
KZS09908.1
JAN86372.1
NA only in CP
Tetratricopeptide repeat protein 39C [Daphnia magna]
Tetratricopeptide repeat protein 39A [Daphnia magna]
3
KZS08204.1
JAN49075.1
JAN58156.1
JAN44218.1
JAN70366.1
JAN49074.1
JAN47274.1
(1 more)
NA only in C
Importin subunit alpha-1 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
Importin subunit alpha-4 [Daphnia magna]
4
JAN61523.1
JAN57486.1
JAN58519.1
JAN76102.1
KZS09622.1
NA only in CP Carboxypeptidase B2 [Daphnia magna]
5
JAN38586.1
JAN31331.1
KZS20920.1
JAN78036.1
NA only in C Oligomeric Golgi complex subunit 8 [Daphnia magna]
6
JAN62118.1
JAN34272.1
JAN59007.1
JAN29476.1
NA only in CP ADP/ATP translocase, partial [Daphnia magna]
7
JAN90467.1
JAN54081.1
JAN46034.1
NA only in C Tubulin beta-4B chain [Daphnia magna]
8
KZS04920.1
JAN33178.1
JAN67728.1
JAN55609.1
JAN50414.1
JAN86991.1
NA only in CP Ribosome biogenesis protein WDR12 [Daphnia magna]
9
JAN35737.1
JAN53431.1
KZS07904.1
JAN53432.1
JAN71433.1
JAN71531.1
NA only in CP Mannosyl-oligosaccharide glucosidase [Daphnia magna]
10
KZS01666.1
KZR95784.1
JAN79828.1
JAN67460.1
JAN61042.1
JAN45945.1
JAN57602.1
(32 more)
0.08474 1.08
Uncharacterized protein APZ42_001605, partial [Daphnia magna]
Uncharacterized protein APZ42_010249, partial [Daphnia magna]
hypothetical protein [Daphnia magna]
hypothetical protein, partial [Daphnia magna]
Vitellogenin-1 precursor [Daphnia magna]
putative Vitellogenin-1 precursor [Daphnia magna]
39S ribosomal protein L22, mitochondrial, partial [Daphnia magna]
https://doi.org/10.1371/journal.pone.0195366.t003
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had different potentials to develop resistance, this may explain why they demonstrated such a
wide range of reactions to CP.
The clones in our study reacted quite variably to the CP, and different proteins were
affected in each. Nevertheless, we suggest that in general Daphnia attempt to counteract the
cytotoxic activity of CP by increasing basic metabolism including the strategy of protein degra-
dation using carboxypeptidase B. Daphnia also probably react to CP by regulating their cell
cycles, e.g. through the activity of cyclin-dependent kinase (Tables 1–3).
In our clones, the absence or down-regulation of such proteins as glutathione S-transferase
theta-1 and 5-oxoprolinase involved in glutathione synthesis, may stem from inhibition by the
affected Daphnia of homeostasis in the redox state of their cells. In addition, Daphnia individ-
uals treated with CP likely down-regulate the processes involved in cell adhesion, transport,
and signaling, (e.g. trafficking protein particle complex, cadherin-23, importin, or ectonucleo-
tide pyrophosphatase/phosphodiesterase) (Tables 1–3). In the cells of more complex organ-
isms, overexpression of the aforementioned processes could lead to cancerogenesis.
It is known that CP induces double strand breaks in DNA that could possibly lead to apo-
ptosis induction [26–28]. We did observe, in the D clone only, a nonsignificant decrease in the
expression of mitochondrial apoptosis-inducing factor 1, clones (S1, S2, and S3 Files). The
apoptosis-inducing factor 3 occurred at a decreased level in the D and S clones, but was not
identified for N clone. On the other hand, the apoptosis inhibitor 5 decreased in the CP-treated
D clone but increased in the CP-treated N and S Daphnia. This suggests that in all the clones,
the process of apoptosis is restrained in the presence of low concentrations of CP; the N and S
clones, however, may be less resistant to the chemical used.
D clone individuals showed no changes in their life history parameters when exposed to the
alkylating agent tested. However, proteome analysis showed increase in the production of vitel-
logenin fused with superoxide dismutase. Chen et al. (2011) studied vitellogenesis in Artemia
parthenogenetica in two reproductive modes, oviparity and ovoviviparity [29]. The vitellogenin
of Artemia was found to possess six copies of the consensus cleavage site, R-X-X-R, and a super-
oxide dismutase (SOD)-like domain at the N-terminus. Different profiles of the oviparous and
ovoviviparous pathways were shown to contain only the SOD-containing subunits. The authors
postulated that these components play an important role in the formation of encysted diapaused
embryos during long-term cell-cycle arrest. Previously, SOD-like domains for vitellogenesis
proteins have been reported in only one crustacean, namely, D. magna [30, 31]. Under favorable
environmental conditions, crustaceans of the Daphnia genus reproduce parthenogenetically.
When conditions deteriorate, these organisms can switch to producing males and haploid sex-
ual resting eggs [32]. We can speculate that animals of clone D interpret CP factor as indicating
deteriorating environmental conditions and prepare themselves for diapause.
As described above, one way of dealing with toxic substances is to avoid it by producing
resting stages able to survive any harsh conditions [33]. In our study, Daphnia of N clone
appeared to take a different strategy. Individuals from this clone cultured in the presence of
CP had many more offspring than those without the pharmaceutical (Fig 3C). Such a phenom-
enon has also been found to be produced by the presence of other stress factors, e.g. D. magna
in the presence of fish kairomone allocate more energy for egg production [34]. In our study,
the production of larger numbers of offspring may be an attempt by the Daphnia to compen-
sate for higher offspring mortality resulting from a predicted toxic environment in the future.
Moreover, based on their proteome profiles, the N clone animals exposed to CP underwent
changes in their metabolic activity and cell organization, which may reflect an adaptation to
the presence of a toxin in the environment.
The reaction of clone S represented another type of strategy taken by Daphnia exposed to
CP. At the level of the individual, we observed a prolongation of the time necessary for
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Daphnia to reach maturity in the presence of the pharmaceutical, which can be explained by
the configuration of the proteome profiles. Vitellogenin, the precursor of main yolk proteins,
is crucial for embryonic development. Kato et al. (2004) found that vitellogenin 1 was the most
abundant polypeptide in the parthenogenetic eggs of D. magna [30]. Our results showed
decreased levels of the vitellogenin-1 precursor-like protein in the CP-treated Daphnia. The
accumulation of vitellogenin, or vitellinis, in oocytes is one of the key events in the ovarian
maturation process. In our experiment, Daphnia cultured with alkylating agent showed lower
levels of the vitellogenin-1 precursor-like protein on the fifth day of incubation. As it takes lon-
ger to accumulate enough proteins to reach maturation, the Daphnia are thus older when
releasing their first eggs.
Recently van Donk et al. (2015), showed multiple pathways by which pharmaceutical com-
pounds may directly and indirectly affect species from different trophic levels [35]. Our
research supports these conclusions. Daphnia is a model organism, a typical representative of
the filter-feeding zooplankton which plays a major role in controlling algal biomass, and likely
play an important role in limiting negative effects on ecosytems of eutrophication [36]. In
addition, cladocerans including Daphnia constitute the primary food of planktivorous fish.
Changes in any of their fitness parameters caused by the presence of pharmaceuticals in the
environment could have a dramatic effect on these planktonic crustaceans, and thus on aquatic
food webs. The structure and composition of the zooplankton community translate directly
into the characteristics of the ichthyofauna which prey on them, and the health of these organ-
isms is essential for fish production in lakes.
In conclusion, our study has demonstrated for the first time that even very low concentra-
tions of CP in freshwater ecosystems can significantly impact aquatic organisms. This contami-
nant can influence both the life history parameters of as well as protein expression in Daphnia.
Our different Daphnia clones employed different strategies to better survive in the contami-
nated environment. Nevertheless, our study provides a cautionary example of the effects of
anthropogenic chemicals on aquatic ecosystems.
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